The US Food and Drug Administration (FDA) last month warned Indian drugmaker Centurion Laboratories over good manufacturing practice (GMP) violations observed at the company’s Gujarat facility last October.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,